SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 6 — Focused Visit (Care-plan review) — Natsume Sōseki

PatientNatsume Sōseki
Date of birth1983-02-09
IdentifiersMRN HR-ET023-SYN; SSN (made up) 000-23-8840
Document date2026-08-03
AuthorHaruka Lindqvist-Mori, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Eleven-week review: urea breath test, repeat endoscopy, anemia, and surveillance. [S]

History of Present Illness

Mr. Natsume returns eleven weeks after diagnosis. He completed the 14 days of vonoprazan-amoxicillin dual therapy, missing no doses, with loose stools that settled after the course. He took vonoprazan each morning for the full eight weeks and stopped it two and a half weeks ago; he has had no epigastric pain since. He has had no tarry stools, vomiting or fainting. His back pain settled within two weeks. He takes iron every other morning and feels much less tired. He fasted this morning for the urea breath test and the repeat endoscopy with Dr. Abrahamsen-Ito. [S]

ElementDetail
Eradication14-day course completed seven weeks ago
VonoprazanEight weeks completed; stopped two and a half weeks ago
SymptomsNo pain, bleeding or tiredness
Testing today13C urea breath test, then repeat endoscopy with scar biopsies; blood count and ferritin

Review of Systems

SystemResultFinding
ConstitutionalNegativeEnergy good; weight up
GastrointestinalNegativeNo epigastric pain, heartburn, vomiting or tarry stools
MusculoskeletalNegativeBack pain gone
PsychiatricNegativeMood good; PHQ-9 3

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Acetaminophen 500 mg oral tablet, one or two tablets by mouth every six hours as needed for headache or pain, no more than 3 g a day (in place of ibuprofen)One or two tablets every six hours as needed; no more than six tablets a dayOral route2026-05-18activeS
Vonoprazan 20 mg oral tablet, one tablet by mouth each morning for eight weeks for gastric ulcer healingOne tablet each morning for eight weeksOral route2026-05-21 to 2026-07-16completedS
Ferrous sulfate 325 mg (65 mg elemental iron) oral tablet, one tablet by mouth every other dayOne tablet every other morningOral route2026-05-21activeS
Vonoprazan 20 mg oral tablet, one extra tablet by mouth each evening for 14 days during eradication therapy (20 mg twice daily with the morning dose)One tablet each evening for 14 daysOral route2026-06-04 to 2026-06-17completedS
Amoxicillin 500 mg oral capsule, two capsules (1 g) by mouth three times daily for 14 daysTwo capsules three times daily for 14 daysOral route2026-06-04 to 2026-06-17completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-08-03Body height159cmS
2026-08-03Body weight53.6kgS
2026-08-03Body mass index (BMI) [Ratio]21.2kg/m2S
2026-08-03Systolic blood pressure118mm[Hg]S
2026-08-03Diastolic blood pressure74mm[Hg]S
2026-08-03Heart rate72/minS
2026-08-03Respiratory rate14/minS
2026-08-03Body temperature36.6CelS
2026-08-03Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-08-03Hemoglobin [Mass/volume] in Blood14g/dL13.2-17.1 g/dLNormalS
2026-08-03MCV [Entitic mean volume] in Red Blood Cells by Automated count85fL80-100 fLNormalS
2026-08-03Ferritin [Mass/volume] in Serum or Plasma46ng/mL30 ng/mL or less indicates iron deficiency (AGA)NormalS
2026-08-03Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]3{score}S
2026-08-03Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]4{score}S

Physical Exam

Vital signs recorded on 2026-08-03; see the Vital Signs section. [S]

SystemFinding
GeneralWell; weight 53.6 kg, BMI 21.2; pulse 72, blood pressure 118/74
ConjunctivaePink
AbdomenSoft and non-tender

Problems

ProblemClinical statusVerificationCodeProvenance
About three weeks of gnawing epigastric pain, worse before meals and at night and eased by food, with two episodes of black, tarry stools ten days ago and iron-deficiency anemia; stable, Glasgow-Blatchford score 4; peptic ulcer suspected and urgent endoscopy bookedresolvedconfirmed R10.13S — Synthetic presenting concern at the index visit, superseded by the diagnosis at endoscopy; its timing echoes his documented stomach illness of May 1910 (D).
Gastric ulcer, 15 mm, on the lesser curvature at the angulus, with recent bleeding (melena) and a clean base at endoscopy (Forrest III); margin biopsies benign; Helicobacter pylori positive; synthetic modern diagnosis for his documented gastric ulcerresolvedconfirmed K25.4S — Synthetic modern diagnosis anchored to his documented gastric ulcer (D); the Helicobacter pylori cause is synthetic.
Helicobacter pylori infection (rapid urease test and histology positive; clarithromycin resistance mutation on biopsy PCR)resolvedconfirmed B96.81S — Synthetic finding at endoscopy; no historical claim is made about the organism in his illness.
Iron-deficiency anemia from chronic blood loss (hemoglobin 11.2 g/dL, MCV 76 fL, ferritin 8 ng/mL)activeconfirmed D50.0S — Synthetic finding at intake.
Acute low back strain after lifting a box of books, without red flags, managed without NSAIDs because of the gastric ulcer; resolvedresolvedconfirmed M54.50S — Synthetic intercurrent illness; not a historical claim.
Prediabetes (hemoglobin A1c 5.8%)activeconfirmed R73.03S — Synthetic finding at the preventive visit; not a claim about his real health at this age.
Chronic atrophic gastritis from Helicobacter pylori, moderate atrophy with focal intestinal metaplasia in the antrum (OLGA stage II, OLIM stage I; open-type endoscopic atrophy); no dysplasia; yearly endoscopic surveillanceactiveconfirmed K29.40S — Synthetic histology finding at the two-week visit; not a historical claim.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
LaboratoryTest of eradication (13C urea breath test)At least four weeks after antibiotics and two weeks after acid suppressionCompleted todayNegative seven weeks after the antibiotics and two and a half weeks off vonoprazan: eradicated
ImagingUpper endoscopy with biopsy of the ulcer marginAt diagnosis; repeat for a gastric ulcer at 8 to 12 weeks to confirm healing and biopsy the scarCompleted todayHealed to a white scar; scar biopsies sent
Medication safetyEradication therapy: adherence and side effectsAt the start and during the courseCompleted todayCourse completed without missed doses; loose stools settled
Medication safetyAcid suppression for ulcer healing (vonoprazan)Daily for eight weeks for a gastric ulcerCompleted todayEight weeks completed; stopped; no long-term acid suppression needed
Medication safetyNSAID avoidanceEvery visitCompleted todayNone since the first visit, including during the back strain
Self-managementBleeding warning signs and when to call 119Every visitCompleted todayNo bleeding; warning signs reviewed for the future
LaboratoryBlood count on oral ironAbout four weeks after starting oral iron, then every three months for a year (CMID)DeferredMissed: the blood count due about four weeks after starting iron was not done because no laboratory visit was booked. No harm judging by today's hemoglobin of 14.0 g/dL and MCV of 85 fL. Corrective action: the three-month count is booked as a laboratory visit with a reminder
LaboratoryFerritinAt the end of the iron course; target 30 ng/mL or more, ideally 50 (CMID)Completed today46 ng/mL: replete, below the ideal of 50; iron continues three months
ExaminationColonoscopy for iron-deficiency anemiaFor iron-deficiency anemia in an adult man, unless an upper source explains it and the anemia corrects (CMID)Not indicatedThe ulcer explained the bleeding and the anemia has corrected; colorectal screening from 45
LaboratoryGastric cancer surveillance: atrophy and intestinal metaplasia stagingEndoscopy yearly after eradication when atrophy or intestinal metaplasia is presentDueNext endoscopy in one year
SurveyStress and depression: PHQ-9 and GAD-7At intake and at the end of the episodeCompleted todayPHQ-9 3 and GAD-7 4, from 7 and 8
Self-managementHepatitis B vaccineTwo doses at least four weeks apartCompleted todayDose 2 given today; series complete

Goal progress:

Immunizations given today: Hepatitis B vaccine (HepB-CpG), dose 2 of 2 [S]

Guideline basis: ACG Clinical Guideline: Treatment of Helicobacter pylori Infection (2024); Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report (2022); Guidelines for the management of Helicobacter pylori infection in Japan: 2016 Revised Edition (2016 (published 2019)); Evidence-based clinical practice guidelines for peptic ulcer disease 2026 (2026); ACG Clinical Guideline: Upper Gastrointestinal and Ulcer Bleeding (2021); Depression and Suicide Risk in Adults: Screening (2023); CMID: Clinical Monitoring Intelligence Database, anemia monograph (2026); Adult Immunization Schedule by Age (2026)

Follow-up: Blood count, ferritin and A1c in three months. Upper endoscopy in one year. Scar biopsy result by phone. Call 119 for black, tarry stools, vomiting blood or fainting. [S]